• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荧光原位杂交异常和CLLU1表达对慢性淋巴细胞白血病预后的影响:来自土耳其的156例患者报告

Impact of Fluorescent In Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey.

作者信息

Abur Ümmet, Oğur Gönül, Akar Ömer Salih, Altundağ Engin, Aymelek Huri Sema, Özatlı Düzgün, Turgut Mehmet

机构信息

Ondokuz Mayıs University Faculty of Medicine, Department of Medical Genetics, Samsun, Turkey.

Ondokuz Mayıs University Faculty of Medicine, Department of Hematology, Samsun, Turkey.

出版信息

Turk J Haematol. 2018 Mar 1;35(1):61-65. doi: 10.4274/tjh.2017.0112. Epub 2017 Nov 13.

DOI:10.4274/tjh.2017.0112
PMID:29129824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5843776/
Abstract

OBJECTIVE

This study evaluates the impact of CLLU1 expression and fluorescent in situ hybridization (FISH) analysis of a group of Turkish chronic lymphocytic leukemia (CLL) patients.

MATERIALS AND METHODS

A total of 156 CLL patients were analyzed by FISH method; 47 of them were also evaluated for CLLU1 expression. Results were correlated with clinical parameters.

RESULTS

FISH aberrations were found in 62% of patients. These aberrations were del13q14 (67%), trisomy 12 (27%), del11q22 (19%), del17p (8%), and 14q32 rearrangements (20%). Overall del11q22 and del17p were associated with the highest mortality rates, shortest overall survival (OS), and highest need for medication. Homozygous del13q14, 14q32 rearrangements, and higher CLLU1 expression correlated with shorter OS.

CONCLUSION

Cytogenetics/FISH analysis is still indicated for routine evaluation of CLL. Special consideration is needed for the poor prognostic implications of del11q22, del17p, 14q32 rearrangements, and homozygous del13q14. The impact of CLLU1 expression is not yet clear and it requires more data before becoming routine in genetic testing in CLL patients.

摘要

目的

本研究评估一组土耳其慢性淋巴细胞白血病(CLL)患者的CLLU1表达及荧光原位杂交(FISH)分析的影响。

材料与方法

采用FISH方法对156例CLL患者进行分析;其中47例还评估了CLLU1表达。结果与临床参数相关。

结果

62%的患者发现FISH异常。这些异常包括13q14缺失(67%)、三体12(27%)、11q22缺失(19%)、17p缺失(8%)和14q32重排(20%)。总体而言,11q22和17p缺失与最高死亡率、最短总生存期(OS)以及最高用药需求相关。纯合性13q14缺失、14q32重排和较高的CLLU1表达与较短的OS相关。

结论

细胞遗传学/FISH分析仍适用于CLL的常规评估。对于11q22、17p、14q32重排和纯合性13q14缺失的不良预后影响需要特别考虑。CLLU1表达的影响尚不清楚,在成为CLL患者基因检测的常规项目之前还需要更多数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/806a/5843776/e174a7d016f0/TJH-35-61-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/806a/5843776/e174a7d016f0/TJH-35-61-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/806a/5843776/e174a7d016f0/TJH-35-61-g1.jpg

相似文献

1
Impact of Fluorescent In Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey.荧光原位杂交异常和CLLU1表达对慢性淋巴细胞白血病预后的影响:来自土耳其的156例患者报告
Turk J Haematol. 2018 Mar 1;35(1):61-65. doi: 10.4274/tjh.2017.0112. Epub 2017 Nov 13.
2
CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.CLLU1表达水平可预测慢性淋巴细胞白血病开始治疗的时间和总生存期。
Eur J Haematol. 2006 Jun;76(6):455-64. doi: 10.1111/j.0902-4441.2005.t01-1-EJH2530.x. Epub 2006 Mar 9.
3
The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.50例中国慢性淋巴细胞白血病患者中CLLU1表达水平的预后评估
Leuk Lymphoma. 2007 Sep;48(9):1785-92. doi: 10.1080/10428190701534416.
4
[Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].[慢性淋巴细胞白血病患者中CLLU1的表达及其预后意义]
Zhonghua Xue Ye Xue Za Zhi. 2007 Nov;28(11):737-40.
5
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.CLLU1 表达在一线治疗后年轻患者和 IGHV 基因突变的慢性淋巴细胞白血病患者中有预后价值。
Haematologica. 2013 Feb;98(2):274-8. doi: 10.3324/haematol.2012.070201. Epub 2012 Aug 16.
6
Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.B细胞慢性淋巴细胞白血病/小淋巴细胞淋巴瘤细胞遗传学异常的荧光原位杂交检测
Leuk Lymphoma. 2004 Aug;45(8):1595-603. doi: 10.1080/10428190410001680546.
7
The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience.慢性淋巴细胞白血病上调基因1(CLLU1)基因表达在慢性淋巴细胞白血病患者中的影响及预后意义:单中心经验
Lab Med. 2020 May 6;51(3):259-264. doi: 10.1093/labmed/lmz058.
8
Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia.分析慢性淋巴细胞白血病患者治疗前后 CLLU1 表达水平。
Eur J Haematol. 2011 May;86(5):405-411. doi: 10.1111/j.1600-0609.2011.01588.x. Epub 2011 Mar 23.
9
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia.CLLU1表达分析为慢性淋巴细胞白血病的风险预测增添了预后信息。
Blood. 2007 Jun 1;109(11):4973-9. doi: 10.1182/blood-2006-11-054916. Epub 2007 Feb 6.
10
CLLU1 as an emerging biomarker in chronic lymphoid leukemia.CLLU1 作为慢性淋巴细胞白血病的一种新兴生物标志物。
Hum Cell. 2024 May;37(3):625-632. doi: 10.1007/s13577-024-01051-4. Epub 2024 Mar 20.

本文引用的文献

1
Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.慢性淋巴细胞白血病中的基因异常:我们所处的位置与前进的方向
Biomed Res Int. 2014;2014:435983. doi: 10.1155/2014/435983. Epub 2014 May 22.
2
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.慢性淋巴细胞白血病的基因突变与治疗结果:CLL8 试验结果。
Blood. 2014 May 22;123(21):3247-54. doi: 10.1182/blood-2014-01-546150. Epub 2014 Mar 20.
3
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion.
13q 双等位基因缺失并不会导致慢性淋巴细胞白血病患者的预后更差:对 627 例单纯 13q 缺失患者的分析。
Br J Haematol. 2013 Oct;163(1):47-54. doi: 10.1111/bjh.12479. Epub 2013 Jul 19.
4
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.CLLU1 表达在一线治疗后年轻患者和 IGHV 基因突变的慢性淋巴细胞白血病患者中有预后价值。
Haematologica. 2013 Feb;98(2):274-8. doi: 10.3324/haematol.2012.070201. Epub 2012 Aug 16.
5
Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study.荧光原位杂交检测 275 例中国 B 细胞慢性淋巴细胞白血病患者的细胞遗传学特征:一项多中心研究。
Chin Med J (Engl). 2011 Aug;124(16):2417-22.
6
Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia.分析慢性淋巴细胞白血病患者治疗前后 CLLU1 表达水平。
Eur J Haematol. 2011 May;86(5):405-411. doi: 10.1111/j.1600-0609.2011.01588.x. Epub 2011 Mar 23.
7
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.在慢性淋巴细胞白血病中,涉及免疫球蛋白重链基因座的14号染色体q32易位可识别出预后不良的疾病亚组。
Br J Haematol. 2008 Aug;142(4):529-37. doi: 10.1111/j.1365-2141.2008.07227.x. Epub 2008 Jun 28.
8
The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.50例中国慢性淋巴细胞白血病患者中CLLU1表达水平的预后评估
Leuk Lymphoma. 2007 Sep;48(9):1785-92. doi: 10.1080/10428190701534416.
9
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.慢性淋巴细胞白血病中的克隆进化:获得与未突变VH相关的高危基因组畸变、对治疗的抗性及生存期短。
Haematologica. 2007 Sep;92(9):1242-5. doi: 10.3324/haematol.10720. Epub 2007 Aug 1.
10
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia.CLLU1表达分析为慢性淋巴细胞白血病的风险预测增添了预后信息。
Blood. 2007 Jun 1;109(11):4973-9. doi: 10.1182/blood-2006-11-054916. Epub 2007 Feb 6.